Upregulated survivin expression in activated T lymphocytes correlates with disease activity in multiple sclerosis

European Journal of Neurology

Volumn 9, Issue 5, 2002, Pages 503-510

  Sharief, M K ^a   Noori, M A ^a   Douglas, M R ^a   Semra, Y K ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; Bcl 2; Disease activity; Multiple sclerosis; Survivin

Indexed keywords

CASPASE 8; PROTEIN BCL 2; SURVIVIN;

APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE DURATION; HUMAN; HUMAN CELL; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

AGE OF ONSET; ANTIGENS, CD95; APOPTOSIS; AUTOIMMUNITY; CARRIER PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; GENE EXPRESSION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAGNETIC RESONANCE IMAGING; MICROTUBULE-ASSOCIATED PROTEINS; MITOGENS; MULTIPLE SCLEROSIS; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; T-LYMPHOCYTES; UP-REGULATION;

EID: 0036042817     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.2002.00454.x     Document Type: Article

References (46)

1. Survivin apoptosis: An interloper between cell death and cell proliferation in cancer
2. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
3. Multiple sclerosis-emerging concepts of disease pathogenesis
4. Biochemical pathways of caspase activation during apoptosis
5. Apoptotic and effector pathways in autoimmunity
6. Expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin
7. Defective T cell Fas function in patients with multiple sclerosis
8. Three differentially expressed survivin cDNA variants encode proteins with distinct antiapoptotic functions
9. Resistance to glucocorticoid-induced apoptosis in PLP peptide-specific T cell clones from patients with progressive MS
10. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis
11. Expression of survivin mRNA in CD34-positive cells
12. Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34+ cells by hematopoietic growth factors: Implication of survivin expression in normal hematopoiesis
13. The role of the Bcl-2 family of apoptosis regulatory proteins in the immune system
14. Escaping cell death: Survival proteins in cancer
15. Active MRI lesion appearance in MS patients is preceded by fluctuations in circulating T-helper 1 and 2 cells
16. Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation
17. Survivin expression correlates with apoptosis resistance after lymphocyte activation and is found preferentially in memory T cells
18. Cross-linking of the Fas/APO-1 antigen suppresses the CD3-mediated signal transduction events in human T lymphocytes
19. CD95′s deadly mission in the immune system
20. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions
21. Impaired apoptosis in mitogen-stimulated lymphocytes of patients with multiple sclerosis
22. Tumor suppressor genes
23. The Bcl-2 family and cell death regulation
24. Apoptosis and cell division
25. Control of apoptosis during angiogenesis by survivin expression in endothelial cells
26. Apoptosis in the effector phase of autoimmune diabetes, multiple sclerosis and thyroiditis
27. Activation-induced apoptosis of autoreactive and alloreactive T lymphocytes in the target organ as a major mechanism of tolerance
28. The central effectors of cell death in the immune system
29. BIRinging chromosomes through cell division - And survivin′ the experience
30. Survivin′ cell-separation anxiety
31. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases
32. Role of Fas-FasL interactions in the pathogenesis and regulation of autoimmune demyelinating disease
33. Serum levels of apoptosis-related molecules in patients with multiple sclerosis and human T-lymphotropic virus Type I-associated myelopathy
34. Fas (t) track to apoptosis in MS - TNF receptors may suppress or potentiate CNS demyelination
35. Overexpression of the apoptosis inhibitor FLIP in T cells correlates with disease activity in multiple sclerosis
36. Impaired Fas-independent apoptosis of T lymphocytes in patients with multiple sclerosis
37. Increased cellular expression of the caspase inhibitor FLIP in intrathecal lymphocytes from patients with multiple sclerosis
38. Heightened expression of survivin in activated T lymphocytes from patients with multiple sclerosis
39. Upregulation of the inhibitor of apoptosis (IAP) proteins in activated T lymphocytes from patients with multiple sclerosis
40. Human survivin is a kinetochore-associated passenger protein
41. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs
42. Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype
43. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli
44. Impaired apoptotic deletion of myelin basic protein-reactive T cells in patients with multiple sclerosis
45. Bcl-2 expressing T lymphocytes in multiple sclerosis lesions
46. Apoptosis in multiple sclerosis